Evotec SE, DE0005664809

Evotec secures USD 2.9 million grant; stock slips to EUR 2.74, down 0.36%

Published on 11/18/2026 at 07:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec received a new USD 2.9 million Gates Foundation grant for a further three years of human stem cell-based drug safety research. On Xetra, the stock closed at EUR 2.75 on Tuesday, November 17, 2026.

Evotec extends Gates Foundation research

  • Evotec received a new USD 2.9 million Gates Foundation grant on November 16, 2026.
  • The three-year project supports human stem cell-based testing for potential fetal development risks in drug candidates.
  • The platform screened more than 5,000 compounds across nine grantee programs during the initial collaboration.
Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec is extending a Gates Foundation-backed research project focused on earlier drug safety decisions. The company received a new USD 2.9 million grant on November 16, 2026, for a further three years of work using human stem cell-based New Approach Methodologies.

PR Newswire reported that the project helps global health researchers identify potential fetal development risks in novel drug candidates. Evotec combines human induced pluripotent stem cell models with industrial-scale screening, AI-supported disease modeling and other drug discovery technologies.

During the initial three-year collaboration, researchers screened more than 5,000 compounds across nine grantee programs. The renewed funding gives researchers continued access to the platform and supports earlier decisions about which candidates should advance toward clinical testing.

Evotec stock traded at EUR 2.74 on Lang & Schwarz at 07:44 CET on Wednesday, November 18, 2026, 0.36 percent below the Xetra close of Tuesday, November 17, 2026.

German equities are covered in the current market reports.

Further updates and analysis are available in more news and analyses on Evotec stock.

Disclaimer...
en | DE0005664809 | EVOTEC SE | boerse | 70529775 | bgmi